Details of the Drug

General Information of Drug (ID: DMZ57Q0)

• Drug Name: CTP-692
• Synonyms: Deutarserine; D-serine-2-d; Deutarserine [USAN]; UNII-OD54L0MH86; OD54L0MH86; SCHEMBL10901499; WHO 11514; (2R)-2-amino-2-deuterio-3-hydroxypropanoic acid; C-21692; 103292-62-2

Indication

Disease Entry	ICD 11	Status	REF
Schizophrenia	6A20	Phase 2	[1]

• Drug Type: Small molecular drug
• Chemical Identifiers:
  Formula: C3H7NO3
  Canonical SMILES: C(C(C(=O)O)N)O
  InChI: InChI=1S/C3H7NO3/c4-2(1-5)3(6)7/h2,5H,1,4H2,(H,6,7)/t2-/m1/s1/i2D
  InChIKey: MTCFGRXMJLQNBG-LIIDHCAMSA-N
• Cross-matching ID:
  PubChem CID: 12219623
  CAS Number: 103292-62-2
  TTD ID: DC52UD
• Drug ADMET Endpoint Profile (DAE)NEW: Click to Jump to the Detailed DAE Information of This Drug

References

• [1] ClinicalTrials.gov (NCT04158687) A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-692 as an Adjunctive Treatment in Adults With Schizophrenia. U.S. National Institutes of Health.